1. Home
  2. FMY vs ATNM Comparison

FMY vs ATNM Comparison

Compare FMY & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FMY
  • ATNM
  • Stock Information
  • Founded
  • FMY 2005
  • ATNM 2000
  • Country
  • FMY United States
  • ATNM United States
  • Employees
  • FMY N/A
  • ATNM N/A
  • Industry
  • FMY Finance/Investors Services
  • ATNM Biotechnology: Pharmaceutical Preparations
  • Sector
  • FMY Finance
  • ATNM Health Care
  • Exchange
  • FMY Nasdaq
  • ATNM Nasdaq
  • Market Cap
  • FMY 49.6M
  • ATNM 51.5M
  • IPO Year
  • FMY N/A
  • ATNM N/A
  • Fundamental
  • Price
  • FMY $12.04
  • ATNM $1.54
  • Analyst Decision
  • FMY
  • ATNM Strong Buy
  • Analyst Count
  • FMY 0
  • ATNM 3
  • Target Price
  • FMY N/A
  • ATNM $4.67
  • AVG Volume (30 Days)
  • FMY 10.1K
  • ATNM 229.8K
  • Earning Date
  • FMY 01-01-0001
  • ATNM 05-09-2025
  • Dividend Yield
  • FMY 6.98%
  • ATNM N/A
  • EPS Growth
  • FMY N/A
  • ATNM N/A
  • EPS
  • FMY N/A
  • ATNM N/A
  • Revenue
  • FMY N/A
  • ATNM N/A
  • Revenue This Year
  • FMY N/A
  • ATNM N/A
  • Revenue Next Year
  • FMY N/A
  • ATNM N/A
  • P/E Ratio
  • FMY N/A
  • ATNM N/A
  • Revenue Growth
  • FMY N/A
  • ATNM N/A
  • 52 Week Low
  • FMY $10.71
  • ATNM $1.03
  • 52 Week High
  • FMY $12.17
  • ATNM $8.64
  • Technical
  • Relative Strength Index (RSI)
  • FMY 50.52
  • ATNM 49.81
  • Support Level
  • FMY $11.83
  • ATNM $1.56
  • Resistance Level
  • FMY $12.13
  • ATNM $1.69
  • Average True Range (ATR)
  • FMY 0.13
  • ATNM 0.11
  • MACD
  • FMY -0.00
  • ATNM -0.01
  • Stochastic Oscillator
  • FMY 55.41
  • ATNM 32.18

About FMY First Trust Motgage Income Fund of Beneficial Interest

First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: